Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest: a statistical analysis plan

JC. Jakobsen, J. Dankiewicz, T. Lange, T. Cronberg, G. Lilja, H. Levin, J. Bělohlávek, C. Callaway, A. Cariou, D. Erlinge, J. Hovdenes, M. Joannidis, P. Nordberg, M. Oddo, P. Pelosi, H. Kirkegaard, G. Eastwood, C. Rylander, M. Saxena, C. Storm,...

. 2020 ; 21 (1) : 831. [pub] 20201007

Language English Country Great Britain

Document type Journal Article, Multicenter Study, Randomized Controlled Trial

BACKGROUND: To date, targeted temperature management (TTM) is the only neuroprotective intervention after resuscitation from cardiac arrest that is recommended by guidelines. The evidence on the effects of TTM is unclear. METHODS/DESIGN: The Targeted Hypothermia Versus Targeted Normothermia After Out-of-hospital Cardiac Arrest (TTM2) trial is an international, multicentre, parallel group, investigator-initiated, randomised, superiority trial in which TTM with a target temperature of 33 °C after cardiac arrest will be compared with a strategy to maintain normothermia and active treatment of fever (≥ 37.8 °C). Prognosticators, outcome assessors, the steering group, the trial coordinating team, and trial statisticians will be blinded to treatment allocation. The primary outcome will be all-cause mortality at 180 days after randomisation. We estimate a 55% mortality in the targeted normothermia group. To detect an absolute risk reduction of 7.5% with an alpha of 0.05 and 90% power, 1900 participants will be enrolled. The secondary neurological outcome will be poor functional outcome (modified Rankin scale 4-6) at 180 days after cardiac arrest. In this paper, a detailed statistical analysis plan is presented, including a comprehensive description of the statistical analyses, handling of missing data, and assessments of underlying statistical assumptions. Final analyses will be conducted independently by two qualified statisticians following the present plan. DISCUSSION: This SAP, which was prepared before completion of enrolment, should increase the validity of the TTM trial by mitigation of analysis-bias.

2nd Department of Medicine 1st Faculty of Medicine Charles University Prague and General University Hospital Prague Czech Republic

Adult Critical Care University Hospital of Wales Cardiff UK

Australian and New Zealand Intensive Care Research Centre Monash University Melbourne Australia

Bankstown Hospital Clinical School and The George Institute for Global Health University of New South Wales Kensington Australia

Clinical Studies Sweden Skåne University Hospital Lund Sweden

Copenhagen Trial Unit Centre for Clinical Intervention Research Department 7812 Rigshospitalet Copenhagen University Hospital Tagensvej 22 Copenhagen Denmark

Department of Anesthesia and Intensive Care Oslo University Hospital Rikshospitalet Oslo Norway

Department of Anesthesiology and Intensive Care Medicine Institute of Clinical Sciences Sahlgrenska Academy University of Gothenburg Gothenburg Sweden

Department of Cardiology Holbæk Hospital Holbæk Denmark

Department of Clinical Sciences Anesthesia and Intensive Care Lund University Skåne University Hospital Lund Sweden

Department of Clinical Sciences Cardiology Lund University Skåne University Hospital Lund Sweden

Department of Clinical Sciences Lund Anesthesia and Intensive Care Lund University Helsingborg Hospital Lund Sweden

Department of Clinical Sciences Neurology Lund University Skåne University Hospital Lund Sweden

Department of Clinical Sciences Research and Education Lund University Skåne University Hospital Lund Sweden

Department of Critical Care Alfred Hospital Melbourne Australia

Department of Emergency Medicine University of Pittsburgh Pittsburgh PA USA

Department of Intensive Care Austin Hospital Heidelberg Australia

Department of Intensive Care Erasme University Hospital Université Libre de Bruxelles Brussels Belgium

Department of Intensive Care Medicine Faculty of Biology and Medicine Centre Hospitalier Universitaire Vaudois University Hospital University of Lausanne Lausanne Switzerland

Department of Medicine Center for Resuscitation Science Karolinska Institute Solna Sweden

Department of Nephrology and Medical Intensive Care Charité Universitätsmedizin Berlin Berlin Germany

Department of Regional Health Research The Faculty of Health Sciences University of Southern Denmark Odense Denmark

Department of Surgical Sciences and Integrated Diagnostics University of Genoa Genoa Italy

Division of Intensive Care and Emergency Medicine Department of Internal Medicine Medical University Innsbruck Innsbruck Austria

Division of Neuroscience Critical Care Department of Anesthesiology and Critical Care Medicine Johns Hopkins University School of Medicine Baltimore MD USA

Medical Intensive Care Unit Cochin University Hospital and Paris Descartes University Paris France

Medical Research Institute of New Zealand Wellington New Zealand

Research Center for Emergency Medicine Department of Clinical Medicine Aarhus University Hospital and Aarhus University Aarhus N Denmark

San Martino Policlinico Hospital IRCCS for Oncology and Neurosciences University of Genoa Genoa Italy

Section of Biostatistics Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

University Collage Dublin Clinical Research Centre St Vincent's University Hospital Dublin Ireland

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020001
003      
CZ-PrNML
005      
20210830101611.0
007      
ta
008      
210728s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13063-020-04654-y $2 doi
035    __
$a (PubMed)33028425
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Jakobsen, Janus Christian $u Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Tagensvej 22, Copenhagen, Denmark. jcj@ctu.dk $u Department of Cardiology, Holbæk Hospital, Holbæk, Denmark. jcj@ctu.dk $u Department of Regional Health Research, The Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. jcj@ctu.dk
245    10
$a Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest: a statistical analysis plan / $c JC. Jakobsen, J. Dankiewicz, T. Lange, T. Cronberg, G. Lilja, H. Levin, J. Bělohlávek, C. Callaway, A. Cariou, D. Erlinge, J. Hovdenes, M. Joannidis, P. Nordberg, M. Oddo, P. Pelosi, H. Kirkegaard, G. Eastwood, C. Rylander, M. Saxena, C. Storm, FS. Taccone, MP. Wise, MPG. Morgan, P. Young, A. Nichol, H. Friberg, S. Ullén, N. Nielsen
520    9_
$a BACKGROUND: To date, targeted temperature management (TTM) is the only neuroprotective intervention after resuscitation from cardiac arrest that is recommended by guidelines. The evidence on the effects of TTM is unclear. METHODS/DESIGN: The Targeted Hypothermia Versus Targeted Normothermia After Out-of-hospital Cardiac Arrest (TTM2) trial is an international, multicentre, parallel group, investigator-initiated, randomised, superiority trial in which TTM with a target temperature of 33 °C after cardiac arrest will be compared with a strategy to maintain normothermia and active treatment of fever (≥ 37.8 °C). Prognosticators, outcome assessors, the steering group, the trial coordinating team, and trial statisticians will be blinded to treatment allocation. The primary outcome will be all-cause mortality at 180 days after randomisation. We estimate a 55% mortality in the targeted normothermia group. To detect an absolute risk reduction of 7.5% with an alpha of 0.05 and 90% power, 1900 participants will be enrolled. The secondary neurological outcome will be poor functional outcome (modified Rankin scale 4-6) at 180 days after cardiac arrest. In this paper, a detailed statistical analysis plan is presented, including a comprehensive description of the statistical analyses, handling of missing data, and assessments of underlying statistical assumptions. Final analyses will be conducted independently by two qualified statisticians following the present plan. DISCUSSION: This SAP, which was prepared before completion of enrolment, should increase the validity of the TTM trial by mitigation of analysis-bias.
650    _2
$a tělesná teplota $7 D001831
650    12
$a kardiopulmonální resuscitace $7 D016887
650    _2
$a horečka $7 D005334
650    _2
$a lidé $7 D006801
650    12
$a hypotermie $7 D007035
650    12
$a terapeutická hypotermie $x škodlivé účinky $7 D007036
650    12
$a zástava srdce mimo nemocnici $x diagnóza $x terapie $7 D058687
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Dankiewicz, Josef $u Department of Clinical Sciences, Cardiology, Lund University, Skåne University Hospital, Lund, Sweden
700    1_
$a Lange, Theis $u Section of Biostatistics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
700    1_
$a Cronberg, Tobias $u Department of Clinical Sciences, Neurology, Lund University, Skåne University Hospital, Lund, Sweden
700    1_
$a Lilja, Gisela $u Department of Clinical Sciences, Neurology, Lund University, Skåne University Hospital, Lund, Sweden
700    1_
$a Levin, Helena $u Department of Clinical Sciences, Research and Education, Lund University, Skåne University Hospital, Lund, Sweden
700    1_
$a Bělohlávek, Jan $u 2nd Department of Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic
700    1_
$a Callaway, Clifton $u Department of Emergency Medicine, University of Pittsburgh, Pittsburgh, PA, USA
700    1_
$a Cariou, Alain $u Medical Intensive Care Unit, Cochin University Hospital (APHP) and Paris Descartes University, Paris, France
700    1_
$a Erlinge, David $u Department of Clinical Sciences, Cardiology, Lund University, Skåne University Hospital, Lund, Sweden
700    1_
$a Hovdenes, Jan $u Department of Anesthesia and Intensive Care, Oslo University Hospital, Rikshospitalet, Oslo, Norway
700    1_
$a Joannidis, Michael $u Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria
700    1_
$a Nordberg, Per $u Department of Medicine, Center for Resuscitation Science, Karolinska Institute, Solna, Sweden
700    1_
$a Oddo, Mauro $u Department of Intensive Care Medicine, Faculty of Biology and Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) - University Hospital, University of Lausanne, Lausanne, Switzerland
700    1_
$a Pelosi, Paolo $u Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Genoa, Italy $u San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, University of Genoa, Genoa, Italy
700    1_
$a Kirkegaard, Hans $u Research Center for Emergency Medicine, Department of Clinical Medicine, Aarhus University Hospital and Aarhus University, Aarhus N, Denmark
700    1_
$a Eastwood, Glenn $u Department of Intensive Care, Austin Hospital, Heidelberg, Australia
700    1_
$a Rylander, Christian $u Department of Anesthesiology and Intensive Care Medicine, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
700    1_
$a Saxena, Manoj $u Bankstown Hospital Clinical School and The George Institute for Global Health, University of New South Wales, Kensington, Australia
700    1_
$a Storm, Christian $u Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany $u Division of Neuroscience Critical Care, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
700    1_
$a Taccone, Fabio Silvio $u Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium
700    1_
$a Wise, Matthew P $u Adult Critical Care, University Hospital of Wales, Cardiff, UK
700    1_
$a Morgan, Matt P G $u Adult Critical Care, University Hospital of Wales, Cardiff, UK
700    1_
$a Young, Paul $u Medical Research Institute of New Zealand, Wellington, New Zealand
700    1_
$a Nichol, Alistair $u University Collage Dublin-Clinical Research Centre, St Vincent's University Hospital, Dublin, Ireland $u Australian and New Zealand Intensive Care-Research Centre, Monash University, Melbourne, Australia $u Department of Critical Care, Alfred Hospital, Melbourne, Australia
700    1_
$a Friberg, Hans $u Department of Clinical Sciences, Anesthesia & Intensive Care, Lund University, Skåne University Hospital, Lund, Sweden
700    1_
$a Ullén, Susann $u Clinical Studies Sweden, Skåne University Hospital, Lund, Sweden
700    1_
$a Nielsen, Niklas $u Department of Clinical Sciences Lund, Anesthesia & Intensive Care, Lund University, Helsingborg Hospital, Lund, Sweden
773    0_
$w MED00163187 $t Trials $x 1745-6215 $g Roč. 21, č. 1 (2020), s. 831
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33028425 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101611 $b ABA008
999    __
$a ok $b bmc $g 1690734 $s 1140447
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 21 $c 1 $d 831 $e 20201007 $i 1745-6215 $m Trials $n Trials $x MED00163187
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...